Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Veronika Andrashko"'
Autor:
Daniela Dudysová, Karolina Janků, Michal Šmotek, Elizaveta Saifutdinova, Jana Kopřivová, Jitka Bušková, Bryce Anthony Mander, Martin Brunovský, Peter Zach, Jakub Korčák, Veronika Andrashko, Michaela Viktorinová, Filip Tylš, Anna Bravermanová, Tom Froese, Tomáš Páleníček, Jiří Horáček
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
Serotonergic agonist psilocybin is a psychedelic with antidepressant potential. Sleep may interact with psilocybin’s antidepressant properties like other antidepressant drugs via induction of neuroplasticity. The main aim of the study was to evalua
Externí odkaz:
https://doaj.org/article/2c60ad15328a4bd09f38d9d502c6a964
Publikováno v:
Frontiers in Psychiatry, Vol 11 (2020)
The rapid antidepressant effect of ketamine has become a breakthrough in the research and treatment of depression. Although predictive and modulating factors of the response to ketamine are broadly studied, little is known about optimal concurrent me
Externí odkaz:
https://doaj.org/article/b2e47c3ca73945cfac07263c3031946b
Autor:
Vojtěch Viktorin, Inga Griškova-Bulanova, Aleksandras Voicikas, Dominika Dojčánová, Peter Zach, Anna Bravermanová, Veronika Andrashko, Filip Tylš, Jakub Korčák, Michaela Viktorinová, Vlastimil Koudelka, Kateřina Hájková, Martin Kuchař, Jiří Horáček, Martin Brunovský, Tomáš Páleníček
Publikováno v:
Journal of Personalized Medicine; Volume 12; Issue 6; Pages: 1004
Journal of personalized medicine, Basel : MDPI, 2022, vol. 12, iss. 6, art. no. 1004, p. [1-13]
Journal of personalized medicine, Basel : MDPI, 2022, vol. 12, iss. 6, art. no. 1004, p. [1-13]
Psilocybin is a classical serotoninergic psychedelic that induces cognitive disruptions similar to psychosis. Gamma activity is affected in psychosis and is tightly related to cognitive processing. The 40 Hz auditory steady-state responses (ASSR) are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41eaa86abf0b1101d6c9026d89f77936
Publikováno v:
Neuroscience Letters. 798:137095
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fbfbf38b332b5d15f6668cfc14fcf28b
https://doi.org/10.1016/j.neulet.2023.137095
https://doi.org/10.1016/j.neulet.2023.137095
Autor:
Martin Brunovsky, Jiri Horacek, Sebastian Olbrich, Torsten Meyer, Veronika Andrashko, Tomas Novak, Erich Seifritz
Objective Ketamine has been shown to be effective in treatment of episodes of major depressive disorder (MDD). This controlled study aimed to analyse the predictive and discriminative power of heart rate (HR) and heart rate variability (HRV) for keta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90212a6820d02a7edcc34ada39e86e04
https://www.zora.uzh.ch/id/eprint/210168/
https://www.zora.uzh.ch/id/eprint/210168/
Autor:
Jakub Korcak, Filip Tylš, Tomáš Páleníček, Karolina Janků, Martin Brunovský, Jana Kopřivová, Jiří Horáček, Daniela Dudysová, Jitka Bušková, Peter Zach, Michaela Viktorinova, Tom Froese, Elizaveta Saifutdinova, Anna Bravermanová, Veronika Andrashko, Bryce A. Mander, Michal Šmotek
Publikováno v:
Frontiers in Pharmacology
Frontiers in Pharmacology, Vol 11 (2020)
Frontiers in Pharmacology, Vol 11 (2020)
Serotonergic agonist psilocybin is a psychedelic with antidepressant potential. Sleep may interact with psilocybin’s antidepressant properties like other antidepressant drugs via induction of neuroplasticity. The main aim of the study was to evalua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be507f527f3b1af9fca39bc1829e2b2e
http://id.nii.ac.jp/1394/00001681/
http://id.nii.ac.jp/1394/00001681/
Autor:
Miloslav, Kopecek, Patrik, Svancer, Veronika, Andrashko, Pavel, Knytl, Barbora, Kohutova, Jiri, Kozeny, Dita, Protopopova, Pavel, Mohr
Publikováno v:
Neuro endocrinology letters. 40(2)
Our aim was to examine the effect of vitamin D deficiency on BMI in patients treated with Multi-acting Receptor Target Antipsychotics (MARTA).We measured serum 25-hydroxyvitamin D [25(OH)D] levels and body mass index (BMI) in patients with (≥1 mont
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7103ff9627ba896a2a6506bba8fecf95
https://pubmed.ncbi.nlm.nih.gov/31785213
https://pubmed.ncbi.nlm.nih.gov/31785213
Publikováno v:
European Neuropsychopharmacology. 29:S389-S390
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::229e120aacc388df81168863e0aebaa5
https://doi.org/10.1016/j.euroneuro.2018.11.592
https://doi.org/10.1016/j.euroneuro.2018.11.592